Zobrazeno 1 - 5
of 5
pro vyhledávání: '"Vlad Cletiu"'
Autor:
Simon P. Fraessle, Claudia Tschulik, Manuel Effenberger, Vlad Cletiu, Maria Gerget, Kilian Schober, Dirk H. Busch, Lothar Germeroth, Christian Stemberger, Mateusz P. Poltorak
Publikováno v:
Communications Biology, Vol 6, Iss 1, Pp 1-7 (2023)
Abstract CAR T cell therapy is a rapidly growing area of oncological treatments having a potential of becoming standard care for multiple indications. Coincidently, CRISPR/Cas gene-editing technology is entering next-generation CAR T cell product man
Externí odkaz:
https://doaj.org/article/4cff20855bed40668525e3196d9e0810
Autor:
Sabine Radisch, Mateusz P. Poltorak, Michaela Wagner, Vlad Cletiu, Christian Radisch, Irina Treise, Steffi Pann, Alexis Weigt, Sophie Artner, Stefan Dreher, Fabian Fechner, Bojana Borjan, Simon P. Fraessle, Manuel Effenberger, Eileen Benke, Gottfried Navratil, Norbert Hentschel, Dirk H. Busch, Thomas Schmidt, Christian Stemberger, Lothar Germeroth
Publikováno v:
Scientific Reports, Vol 12, Iss 1, Pp 1-13 (2022)
Abstract Large-scale target cell isolation from patient blood preparations is one of the critical operations during drug product manufacturing for personalized cell therapy in immuno-oncology. Use of high-affinity murine antibody coated magnetic nano
Externí odkaz:
https://doaj.org/article/37dedf42770b4fb0b3ef21597568f1d5
Autor:
Simon P. Fraessle, Claudia Tschulik, Manuel Effenberger, Vlad Cletiu, Maria Gerget, Kilian Schober, Dirk H. Busch, Lothar Germeroth, Christian Stemberger, Mateusz P. Poltorak
CAR T cell therapy is a rapidly growing area of oncological treatments having a potential of becoming standard care for multiple indications. Coincidently, CRISPR/Cas gene-editing technology is entering next-generation CAR T cell product manufacturin
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6142191b8f2dde5414e580b20f9fa5ea
https://doi.org/10.1101/2022.11.08.515608
https://doi.org/10.1101/2022.11.08.515608
Autor:
Sabine Radisch, Mateusz P. Poltorak, Michaela Wagner, Vlad Cletiu, Christian Radisch, Irina Treise, Steffi Pann, Alexis Weigt, Sophie Artner, Stefan Dreher, Fabian Fechner, Bojana Borjan, Simon P. Fraessle, Manuel Effenberger, Eileen Benke, Gottfried Navratil, Norbert Hentschel, Dirk H. Busch, Thomas Schmidt, Christian Stemberger, Lothar Germeroth
Publikováno v:
Scientific reports. 12(1)
Large-scale target cell isolation from patient blood preparations is one of the critical operations during drug product manufacturing for personalized cell therapy in immuno-oncology. Use of high-affinity murine antibody coated magnetic nanoparticles
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77077f675061d0e7b83bec16947d969b
https://pubmed.ncbi.nlm.nih.gov/35449227
https://pubmed.ncbi.nlm.nih.gov/35449227
Autor:
Stefan Dreher, David G. Kugler, Mateusz Pawel Poltorak, Bojana Borjan, Christian Stemberger, Lothar Germeroth, Michaela Wagner, Martin Turk, Juergen M. Plitzko, Dirk H. Busch, Claudia Tschulik, Seamus Ragan, Manuel Effenberger, Vlad Cletiu, Patricia Graef, Thomas Schmidt, Simon P. Fraessle
Publikováno v:
Scientific Reports
Scientific Reports, Vol 10, Iss 1, Pp 1-15 (2020)
Scientific Reports, Vol 10, Iss 1, Pp 1-15 (2020)
T cell activation is a cornerstone in manufacturing of T cell-based therapies, and precise control over T cell activation is important in the development of the next generation T-cell based therapeutics. This need cannot be fulfilled by currently ava
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a4843928088aa78172b9e995707c3be
https://hdl.handle.net/21.11116/0000-0007-DF9E-D21.11116/0000-0007-DFA0-921.11116/0000-0007-DFA1-821.11116/0000-0007-DFA2-7
https://hdl.handle.net/21.11116/0000-0007-DF9E-D21.11116/0000-0007-DFA0-921.11116/0000-0007-DFA1-821.11116/0000-0007-DFA2-7